home / stock / abvc / abvc news

ABVC News and Press, ABVC BioPharma Inc. From 04/24/24

Stock Information
Company Name: ABVC BioPharma Inc.
Stock Symbol: ABVC
Market: OTC
Website: abvcpharma.com
Menu
ABVC ABVC Quote ABVC Short ABVC News ABVC Articles ABVC Message Board
Get ABVC Alerts

News, Short Squeeze, Breakout and More Instantly...
ABVC - BACK, ZPTA and ABVC are among premarket gainers

2024-04-24 09:12:50 ET More on premarket gainers and stock Altamira Therapeutics Ltd. 2023 Q4 - Results - Earnings Call Presentation Altamira Therapeutics Ltd. (CYTO) Q4 2023 Earnings Call Transcript B. Riley Financial: Audit Risk May Have Potential Rewards B...
ABVC - US Companies Moving the Markets, Evening edition
Tue, Apr 23, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States Cyngn Inc. (CYN) fell 5.8% to $0.114 on volume of 321,909,962 shares Pineapple Energy Inc. (PEGY) rose 23.6% to $0.0566 on volume of 180,092,924 shares NewGenIvf Group Limited (NIVF) rose 74.2% to $2.23 on volume of 136,563,105 shares...

ABVC - AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share

FREMONT, CA, April 18, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire — ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and Oncology/Hematology, announced to...

ABVC - ABVC BioPharma executes licensing agreement with OncoX

2024-04-17 09:19:47 ET More on ABVC BioPharma ABVC Biopharma stock climbs on deal for its oncology/hematology products Financial information for ABVC BioPharma Read the full article on Seeking Alpha For further details see: ABVC BioPharma executes licensi...
ABVC - ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M

FREMONT, CA  - ( NewMediaWire ) - April 17, 2024 -   ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and Oncology/Hematology, announced today that the Comp...

ABVC - ABVC Biopharma stock climbs on deal for its oncology/hematology products

2024-04-10 09:23:05 ET More on ABVC BioPharma Financial information for ABVC BioPharma Read the full article on Seeking Alpha For further details see: ABVC Biopharma stock climbs on deal for its oncology/hematology products

ABVC - Notable Newsmakers

2024-04-10 09:19:47 ET DENVER, Colo., Apr 10, 2024 ( 247marketnews.com )- ABVC BioPharma, Inc. (NASDAQ: ABVC ), Clearmind Medicine Inc. (NASDAQ: CMND ), Brera Holding (NASDAQ: BREA ), Goldman Sachs (NYSE: GS ), and JP Morgan (NYSE: JPM ). ABVC B...
ABVC - ABVC BioPharma Signs Global Licensing Term Sheet for Its Oncology/Hematology Products

2024-04-10 08:45:46 ET DENVER, Colo., Apr 10, 2024 ( 247marketnews.com )- ABVC BioPharma, Inc. (NASDAQ: ABVC ) stated that it entered into a term sheet with OncoX BioPharma, Inc. for ABVC’s Oncology/Hematology pipeline and is set to receive $50,000,000 as licensing fees in th...

ABVC - ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50M

FREMONT, CA, April 10, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and Oncology/Hematology, announced toda...

ABVC - VERI, CHEK and MESO are among pre market gainers

2024-03-27 08:24:20 ET More on premarket gainers & stock Veritone: Not An AI Stock To Bank On Veritone, Inc. (VERI) Q4 2023 Earnings Call Transcript Mesoblast Limited (MESO) Q2 2024 Earnings Call Transcript Mesoblast gains as FDA backs regulatory plans fo...
Previous 10 Next 10